pubmed-article:9040837 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0003993 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0010583 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0013089 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0032952 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0042679 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
pubmed-article:9040837 | lifeskim:mentions | umls-concept:C0439743 | lld:lifeskim |
pubmed-article:9040837 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:9040837 | pubmed:dateCreated | 1997-3-17 | lld:pubmed |
pubmed-article:9040837 | pubmed:abstractText | To determine response rate and remission as well as survival times for dogs with multicentric lymphoma treated first with doxorubicin alone or in combination with asparaginase and then with cyclophosphamide, vincristine sulfate, and prednisone (CVP) and to identify prevalence of toxicoses associated with this protocol and factors associated with prognosis. | lld:pubmed |
pubmed-article:9040837 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:language | eng | lld:pubmed |
pubmed-article:9040837 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9040837 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9040837 | pubmed:month | Feb | lld:pubmed |
pubmed-article:9040837 | pubmed:issn | 0003-1488 | lld:pubmed |
pubmed-article:9040837 | pubmed:author | pubmed-author:OgilvieG KGK | lld:pubmed |
pubmed-article:9040837 | pubmed:author | pubmed-author:GetzyD MDM | lld:pubmed |
pubmed-article:9040837 | pubmed:author | pubmed-author:MallinckrodtC... | lld:pubmed |
pubmed-article:9040837 | pubmed:author | pubmed-author:ValeriusK DKD | lld:pubmed |
pubmed-article:9040837 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9040837 | pubmed:day | 15 | lld:pubmed |
pubmed-article:9040837 | pubmed:volume | 210 | lld:pubmed |
pubmed-article:9040837 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9040837 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9040837 | pubmed:pagination | 512-6 | lld:pubmed |
pubmed-article:9040837 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:meshHeading | pubmed-meshheading:9040837-... | lld:pubmed |
pubmed-article:9040837 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9040837 | pubmed:articleTitle | Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). | lld:pubmed |
pubmed-article:9040837 | pubmed:affiliation | Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523, USA. | lld:pubmed |
pubmed-article:9040837 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9040837 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9040837 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9040837 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9040837 | lld:pubmed |